5/ Bezugnehmend auf einen JAMA Research Letter von Nguyen et al. schrieb LEITLINIENWATCH in 01/25 über potentiell problematische „finanzielle Zuwendungen an Peer-Reviewer wissenschaftlicher Zeitschriften“: https://t.co/ZyLVPwhmiG“ https://t.co/E0Tr76Rw33
Payments by Drug and Medical Device Manufacturers to US Peer Reviewers of Major Medical Journals.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Oct 2024 – Sep 2025Where it's discussed
-
X / Twitter291 posts
-
News21 articles
-
Facebook5 posts
-
Reddit5 posts
-
Blogs5 articles
-
YouTube2 videos
AI synopsis
What people are saying
The group shows strong disagreement with the article, as evidenced by phrases like 'system IS corrupt' and 'disgusting', highlighting outrage and suspicion toward the peer review process. The tone is assertive and confrontational, reflecting concern about the systemic influence of financial interests on medical research, which underscores the high impact and engagement levels.
Most discussions strongly condemn the practice, describing it as corruption or payola, indicating a high level of disagreement with the integrity of the peer review system.
Posts focus heavily on exposing unethical conduct, which suggests a neutral to moderate level of curiosity but not deep academic engagement.
Multiple posts analyze the implications, mention specific figures and journals, and discuss broader systemic issues, showing active and deep involvement.
The discussions emphasize the potential for widespread influence on medical research and public trust, portraying a significant impact on the reputation of scholarly publishing.
Abstract in brief
- Drug and medical device manufacturers often make payments to peer reviewers of major medical journals, which raises concerns about potential conflicts of interest.
- These payments can influence the objectivity and integrity of the peer review process, impacting the quality of published research.
- Transparency around such financial relationships is crucial to maintain trust in medical literature and ensure unbiased reporting of findings.
Top posts
Most liked on X and BlueskyDurante il COVlD, almeno il 54% dei revisori degli studi di riviste mediche e scientifiche, ha ricevuto denaro per almeno 1,06 miliardi di dollari dalle grandi aziende farmaceutiche, secondo quanto riportato da un nuovo studio su JAMA. 10.1001/jama.2024.17681 https://t.co/HrN79DYK7u
This study characterizes payments by drug and medical device manufacturers to US peer reviewers of major medical journals. https://t.co/uo74UIefhY https://t.co/JtPgo0fQgc
@grok @RayFinkle5859 @SciGuardians @Jikkyleaks @grok, you are forgetting to input the information regarding the Bayh-Dole Act and this publication explaining predatory journal behaviors into your metric requirements for prestige. Please consider these when you answer. https://t.co/hHwst7lhpV
@grok @RayFinkle5859 @tunejunkE @Jikkyleaks @elonmusk @grok since you are refusing to answer me please give me a review of this article. https://t.co/hHwst7lhpV
@JAMAPsych You jerks are so freaking bought. We see you and it's disgusting. Here's your own freaking research - https://t.co/5DmTnqtqpe
All mentions
Payments to Peer Reviewers: A Transparency Concern in Medicine
Nearly $1.06 billion was paid to US-based peer reviewers by pharmaceutical and medical device manufacturers between 2020 and 2022. This raises concerns about potential conflicts of interest and the integrity of the peer…
Exposed: $1.06 Billion Paid to Peer Reviewers of Top Medical Journals
RT @drjasonfung: Holy Crap. Pharma companies paid over $1 Billion from 2020-2022 to influence medical literature. Billion, with a B. That e…
@KrutikaKuppalli He's right, the system IS corrupt. Peer review payola: https://t.co/TSQjpkB11G Paid for/false ghost written research: https://t.co/cYJBIwwV3I Exposed corruption: https://t.co/zznv65vj4A
@danc457324 @johnpetersontx @DrNeilStone The major medical journals & the peer review system are corrupted. It's almost to the point where if it appears in JAMA/BMS/Lancet etc., and peer reviewed, it's a red flag. Ghost writers: https://t.co/cYJBIwwnea Payola to Peer reviewers: https://t.co/TSQjpkAtc8
@GregoryBolin18 @DiedSuddenly_ Payments by Drug and Medical Device Manufacturers to US Peer Reviewers of Major Medical Journals JAMA Published Online: October 10, 2024 2024;332;(17):1480-1482. doi:10.1001/jama.2024.17681 Paid narratives
@RachelTrue @DiedSuddenly_ Payments by Drug and Medical Device Manufacturers to US Peer Reviewers of Major Medical Journals JAMA Published Online: October 10, 2024 2024;332;(17):1480-1482. doi:10.1001/jama.2024.17681
@Jennifer__914 @DiedSuddenly_ Payments by Drug and Medical Device Manufacturers to US Peer Reviewers of Major Medical Journals | Medical Devices and Equipment | JAMA | JAMA Network JAMA Published Online: October 10, 2024 2024;332;(17):1480-1482. doi:10.1001/jama.2024.17681
RT @jathorpmfm: https://t.co/mgRIph0zUD $1.06 BILLION paid to New England Journal of Medicine (NEJM) REVIEWERS! David-Dan Nguyen et al pub…
desprende de una carta de investigación publicada la semana pasada en la revista Journal of the American Medical Association (JAMA). https://t.co/OHQ9DdNC67
RT @drjasonfung: Holy Crap. Pharma companies paid over $1 Billion from 2020-2022 to influence medical literature. Billion, with a B. That e…
@JAMAPsych You jerks are so freaking bought. We see you and it's disgusting. Here's your own freaking research - https://t.co/5DmTnqtqpe
@Altassistent @derkanalraeumer @rama_lama_lam @BBarucker @Quo_vadis_BRD @BrinkmannLab @DirkBrockmann @alena_buyx @CiesekSandra @c_drosten @FuestClemens @HallekMichael argumentum ad verecundiam https://t.co/V0URbUxJan. https://t.co/JGzjkF4FYR. PS: an der Preprint - Version wird gearbeitet. https://t.co/97naV7gOt8
RT @missyTHX1138: @grok @RayFinkle5859 @SciGuardians @Jikkyleaks @grok, you are forgetting to input the information regarding the Bayh-Dole…
RT @missyTHX1138: @grok @RayFinkle5859 @SciGuardians @Jikkyleaks @grok, you are forgetting to input the information regarding the Bayh-Dole…
RT @missyTHX1138: @grok @RayFinkle5859 @SciGuardians @Jikkyleaks @grok, you are forgetting to input the information regarding the Bayh-Dole…
RT @missyTHX1138: @grok @RayFinkle5859 @SciGuardians @Jikkyleaks @grok, you are forgetting to input the information regarding the Bayh-Dole…
RT @missyTHX1138: @grok @RayFinkle5859 @SciGuardians @Jikkyleaks @grok, you are forgetting to input the information regarding the Bayh-Dole…
RT @missyTHX1138: @grok @RayFinkle5859 @SciGuardians @Jikkyleaks @grok, you are forgetting to input the information regarding the Bayh-Dole…
RT @missyTHX1138: @grok @RayFinkle5859 @SciGuardians @Jikkyleaks @grok, you are forgetting to input the information regarding the Bayh-Dole…
@grok @RayFinkle5859 @SciGuardians @Jikkyleaks @grok, you are forgetting to input the information regarding the Bayh-Dole Act and this publication explaining predatory journal behaviors into your metric requirements for prestige. Please consider these when you answer. https://t.co/hHwst7lhpV
@grok @RayFinkle5859 @tunejunkE @Jikkyleaks @elonmusk @grok since you are refusing to answer me please give me a review of this article. https://t.co/hHwst7lhpV
製薬会社や医療機器メーカーが 科学の権威を事実上コントロール 査読システムの問題は 以前から指摘も [製薬会社や医療機器企業からの 主要医学雑誌査読者へのお金の流れ] https://t.co/2rBKhutYjK 画像❷❸❹からも長年の問題と https://t.co/xJ9gavVP45 変化に期待 https://t.co/dy3nYW1p0W https://t.co/k9cGwlamqR https://t.co/F9wF6dybYQ
14. Payments by Drug and Medical Device Manufacturers to US Peer Reviewers of Major Medical Journals https://t.co/IZIcxebYQc
RT @jathorpmfm: https://t.co/mgRIph0zUD $1.06 BILLION paid to New England Journal of Medicine (NEJM) REVIEWERS! David-Dan Nguyen et al pub…
RT @Quo_vadis_BRD: 5/ Bezugnehmend auf einen JAMA Research Letter von Nguyen et al. schrieb LEITLINIENWATCH in 01/25 über potentiell proble…
RT @3stars67664378:
RT @Quo_vadis_BRD: 5/ Bezugnehmend auf einen JAMA Research Letter von Nguyen et al. schrieb LEITLINIENWATCH in 01/25 über potentiell proble…
RT @Quo_vadis_BRD: 5/ Bezugnehmend auf einen JAMA Research Letter von Nguyen et al. schrieb LEITLINIENWATCH in 01/25 über potentiell proble…
RT @Quo_vadis_BRD: 5/ Bezugnehmend auf einen JAMA Research Letter von Nguyen et al. schrieb LEITLINIENWATCH in 01/25 über potentiell proble…
RT @Quo_vadis_BRD: 5/ Bezugnehmend auf einen JAMA Research Letter von Nguyen et al. schrieb LEITLINIENWATCH in 01/25 über potentiell proble…
RT @Quo_vadis_BRD: 5/ Bezugnehmend auf einen JAMA Research Letter von Nguyen et al. schrieb LEITLINIENWATCH in 01/25 über potentiell proble…
5/ Bezugnehmend auf einen JAMA Research Letter von Nguyen et al. schrieb LEITLINIENWATCH in 01/25 über potentiell problematische „finanzielle Zuwendungen an Peer-Reviewer wissenschaftlicher Zeitschriften“: https://t.co/ZyLVPwhmiG“ https://t.co/E0Tr76Rw33
RT @Sabisteb: @AskPerplexity @alexschtuder @PEI_Germany Hast Du dabei die wissenschaftliche Zensur von Daten bedacht, die Daten, die der Ph…
@AskPerplexity @alexschtuder @PEI_Germany Hast Du dabei die wissenschaftliche Zensur von Daten bedacht, die Daten, die der Pharmaindustrie missfallen, zensiert und unterdrückt werden? https://t.co/5nOHAZOWWn https://t.co/rnUeuNA2nt https://t.co/NeeuLOFRLO
@yukosyamamoto こちらの画像もどうぞ。回転ドア(癒着) https://t.co/C1H0lMOQ0D https://t.co/HBNHlVqwLw
RT @jathorpmfm: https://t.co/mgRIph0zUD $1.06 BILLION paid to New England Journal of Medicine (NEJM) REVIEWERS! David-Dan Nguyen et al pub…
RT @jathorpmfm: https://t.co/mgRIph0zUD $1.06 BILLION paid to New England Journal of Medicine (NEJM) REVIEWERS! David-Dan Nguyen et al pub…
RT @drjasonfung: Holy Crap. Pharma companies paid over $1 Billion from 2020-2022 to influence medical literature. Billion, with a B. That e…
RT @jathorpmfm: https://t.co/mgRIph0zUD $1.06 BILLION paid to New England Journal of Medicine (NEJM) REVIEWERS! David-Dan Nguyen et al pub…
RT @jathorpmfm: https://t.co/mgRIph0zUD $1.06 BILLION paid to New England Journal of Medicine (NEJM) REVIEWERS! David-Dan Nguyen et al pub…
RT @jathorpmfm: https://t.co/mgRIph0zUD $1.06 BILLION paid to New England Journal of Medicine (NEJM) REVIEWERS! David-Dan Nguyen et al pub…
RT @jathorpmfm: https://t.co/mgRIph0zUD $1.06 BILLION paid to New England Journal of Medicine (NEJM) REVIEWERS! David-Dan Nguyen et al pub…
RT @jathorpmfm: https://t.co/mgRIph0zUD $1.06 BILLION paid to New England Journal of Medicine (NEJM) REVIEWERS! David-Dan Nguyen et al pub…
RT @jathorpmfm: https://t.co/mgRIph0zUD $1.06 BILLION paid to New England Journal of Medicine (NEJM) REVIEWERS! David-Dan Nguyen et al pub…
RT @jathorpmfm: https://t.co/mgRIph0zUD $1.06 BILLION paid to New England Journal of Medicine (NEJM) REVIEWERS! David-Dan Nguyen et al pub…
RT @jathorpmfm: https://t.co/mgRIph0zUD $1.06 BILLION paid to New England Journal of Medicine (NEJM) REVIEWERS! David-Dan Nguyen et al pub…
RT @jathorpmfm: https://t.co/mgRIph0zUD $1.06 BILLION paid to New England Journal of Medicine (NEJM) REVIEWERS! David-Dan Nguyen et al pub…
RT @jathorpmfm: https://t.co/mgRIph0zUD $1.06 BILLION paid to New England Journal of Medicine (NEJM) REVIEWERS! David-Dan Nguyen et al pub…
RT @jathorpmfm: https://t.co/mgRIph0zUD $1.06 BILLION paid to New England Journal of Medicine (NEJM) REVIEWERS! David-Dan Nguyen et al pub…
RT @jathorpmfm: https://t.co/mgRIph0zUD $1.06 BILLION paid to New England Journal of Medicine (NEJM) REVIEWERS! David-Dan Nguyen et al pub…
RT @jathorpmfm: https://t.co/mgRIph0zUD $1.06 BILLION paid to New England Journal of Medicine (NEJM) REVIEWERS! David-Dan Nguyen et al pub…
RT @jathorpmfm: https://t.co/mgRIph0zUD $1.06 BILLION paid to New England Journal of Medicine (NEJM) REVIEWERS! David-Dan Nguyen et al pub…
RT @jathorpmfm: https://t.co/mgRIph0zUD $1.06 BILLION paid to New England Journal of Medicine (NEJM) REVIEWERS! David-Dan Nguyen et al pub…
RT @jathorpmfm: https://t.co/mgRIph0zUD $1.06 BILLION paid to New England Journal of Medicine (NEJM) REVIEWERS! David-Dan Nguyen et al pub…
RT @jathorpmfm: https://t.co/mgRIph0zUD $1.06 BILLION paid to New England Journal of Medicine (NEJM) REVIEWERS! David-Dan Nguyen et al pub…
RT @jathorpmfm: https://t.co/mgRIph0zUD $1.06 BILLION paid to New England Journal of Medicine (NEJM) REVIEWERS! David-Dan Nguyen et al pub…
RT @jathorpmfm: https://t.co/mgRIph0zUD $1.06 BILLION paid to New England Journal of Medicine (NEJM) REVIEWERS! David-Dan Nguyen et al pub…
RT @jathorpmfm: https://t.co/mgRIph0zUD $1.06 BILLION paid to New England Journal of Medicine (NEJM) REVIEWERS! David-Dan Nguyen et al pub…
RT @jathorpmfm: https://t.co/mgRIph0zUD $1.06 BILLION paid to New England Journal of Medicine (NEJM) REVIEWERS! David-Dan Nguyen et al pub…
RT @jathorpmfm: https://t.co/mgRIph0zUD $1.06 BILLION paid to New England Journal of Medicine (NEJM) REVIEWERS! David-Dan Nguyen et al pub…
RT @jathorpmfm: https://t.co/mgRIph0zUD $1.06 BILLION paid to New England Journal of Medicine (NEJM) REVIEWERS! David-Dan Nguyen et al pub…
RT @jathorpmfm: https://t.co/mgRIph0zUD $1.06 BILLION paid to New England Journal of Medicine (NEJM) REVIEWERS! David-Dan Nguyen et al pub…
RT @jathorpmfm: https://t.co/mgRIph0zUD $1.06 BILLION paid to New England Journal of Medicine (NEJM) REVIEWERS! David-Dan Nguyen et al pub…
RT @jathorpmfm: https://t.co/mgRIph0zUD $1.06 BILLION paid to New England Journal of Medicine (NEJM) REVIEWERS! David-Dan Nguyen et al pub…
RT @jathorpmfm: https://t.co/mgRIph0zUD $1.06 BILLION paid to New England Journal of Medicine (NEJM) REVIEWERS! David-Dan Nguyen et al pub…
RT @jathorpmfm: https://t.co/mgRIph0zUD $1.06 BILLION paid to New England Journal of Medicine (NEJM) REVIEWERS! David-Dan Nguyen et al pub…
RT @jathorpmfm: https://t.co/mgRIph0zUD $1.06 BILLION paid to New England Journal of Medicine (NEJM) REVIEWERS! David-Dan Nguyen et al pub…
RT @jathorpmfm: https://t.co/mgRIph0zUD $1.06 BILLION paid to New England Journal of Medicine (NEJM) REVIEWERS! David-Dan Nguyen et al pub…
RT @jathorpmfm: https://t.co/mgRIph0zUD $1.06 BILLION paid to New England Journal of Medicine (NEJM) REVIEWERS! David-Dan Nguyen et al pub…
RT @jathorpmfm: https://t.co/mgRIph0zUD $1.06 BILLION paid to New England Journal of Medicine (NEJM) REVIEWERS! David-Dan Nguyen et al pub…
RT @jathorpmfm: https://t.co/mgRIph0zUD $1.06 BILLION paid to New England Journal of Medicine (NEJM) REVIEWERS! David-Dan Nguyen et al pub…
RT @jathorpmfm: https://t.co/mgRIph0zUD $1.06 BILLION paid to New England Journal of Medicine (NEJM) REVIEWERS! David-Dan Nguyen et al pub…
RT @jathorpmfm: https://t.co/mgRIph0zUD $1.06 BILLION paid to New England Journal of Medicine (NEJM) REVIEWERS! David-Dan Nguyen et al pub…
RT @jathorpmfm: https://t.co/mgRIph0zUD $1.06 BILLION paid to New England Journal of Medicine (NEJM) REVIEWERS! David-Dan Nguyen et al pub…
RT @jathorpmfm: https://t.co/mgRIph0zUD $1.06 BILLION paid to New England Journal of Medicine (NEJM) REVIEWERS! David-Dan Nguyen et al pub…
RT @jathorpmfm: https://t.co/mgRIph0zUD $1.06 BILLION paid to New England Journal of Medicine (NEJM) REVIEWERS! David-Dan Nguyen et al pub…
RT @jathorpmfm: https://t.co/mgRIph0zUD $1.06 BILLION paid to New England Journal of Medicine (NEJM) REVIEWERS! David-Dan Nguyen et al pub…
RT @jathorpmfm: https://t.co/mgRIph0zUD $1.06 BILLION paid to New England Journal of Medicine (NEJM) REVIEWERS! David-Dan Nguyen et al pub…
RT @jathorpmfm: https://t.co/mgRIph0zUD $1.06 BILLION paid to New England Journal of Medicine (NEJM) REVIEWERS! David-Dan Nguyen et al pub…
RT @jathorpmfm: https://t.co/mgRIph0zUD $1.06 BILLION paid to New England Journal of Medicine (NEJM) REVIEWERS! David-Dan Nguyen et al pub…
RT @jathorpmfm: https://t.co/mgRIph0zUD $1.06 BILLION paid to New England Journal of Medicine (NEJM) REVIEWERS! David-Dan Nguyen et al pub…
RT @jathorpmfm: https://t.co/mgRIph0zUD $1.06 BILLION paid to New England Journal of Medicine (NEJM) REVIEWERS! David-Dan Nguyen et al pub…
RT @jathorpmfm: https://t.co/mgRIph0zUD $1.06 BILLION paid to New England Journal of Medicine (NEJM) REVIEWERS! David-Dan Nguyen et al pub…
RT @jathorpmfm: https://t.co/mgRIph0zUD $1.06 BILLION paid to New England Journal of Medicine (NEJM) REVIEWERS! David-Dan Nguyen et al pub…
RT @jathorpmfm: https://t.co/mgRIph0zUD $1.06 BILLION paid to New England Journal of Medicine (NEJM) REVIEWERS! David-Dan Nguyen et al pub…
RT @jathorpmfm: https://t.co/mgRIph0zUD $1.06 BILLION paid to New England Journal of Medicine (NEJM) REVIEWERS! David-Dan Nguyen et al pub…
RT @jathorpmfm: https://t.co/mgRIph0zUD $1.06 BILLION paid to New England Journal of Medicine (NEJM) REVIEWERS! David-Dan Nguyen et al pub…
RT @jathorpmfm: https://t.co/mgRIph0zUD $1.06 BILLION paid to New England Journal of Medicine (NEJM) REVIEWERS! David-Dan Nguyen et al pub…
RT @jathorpmfm: https://t.co/mgRIph0zUD $1.06 BILLION paid to New England Journal of Medicine (NEJM) REVIEWERS! David-Dan Nguyen et al pub…
RT @jathorpmfm: https://t.co/mgRIph0zUD $1.06 BILLION paid to New England Journal of Medicine (NEJM) REVIEWERS! David-Dan Nguyen et al pub…
RT @jathorpmfm: https://t.co/mgRIph0zUD $1.06 BILLION paid to New England Journal of Medicine (NEJM) REVIEWERS! David-Dan Nguyen et al pub…
RT @jathorpmfm: https://t.co/mgRIph0zUD $1.06 BILLION paid to New England Journal of Medicine (NEJM) REVIEWERS! David-Dan Nguyen et al pub…
RT @jathorpmfm: https://t.co/mgRIph0zUD $1.06 BILLION paid to New England Journal of Medicine (NEJM) REVIEWERS! David-Dan Nguyen et al pub…
RT @jathorpmfm: https://t.co/mgRIph0zUD $1.06 BILLION paid to New England Journal of Medicine (NEJM) REVIEWERS! David-Dan Nguyen et al pub…
RT @jathorpmfm: https://t.co/mgRIph0zUD $1.06 BILLION paid to New England Journal of Medicine (NEJM) REVIEWERS! David-Dan Nguyen et al pub…
RT @jathorpmfm: https://t.co/mgRIph0zUD $1.06 BILLION paid to New England Journal of Medicine (NEJM) REVIEWERS! David-Dan Nguyen et al pub…
RT @jathorpmfm: https://t.co/mgRIph0zUD $1.06 BILLION paid to New England Journal of Medicine (NEJM) REVIEWERS! David-Dan Nguyen et al pub…
RT @jathorpmfm: https://t.co/mgRIph0zUD $1.06 BILLION paid to New England Journal of Medicine (NEJM) REVIEWERS! David-Dan Nguyen et al pub…
RT @jathorpmfm: https://t.co/mgRIph0zUD $1.06 BILLION paid to New England Journal of Medicine (NEJM) REVIEWERS! David-Dan Nguyen et al pub…
RT @jathorpmfm: https://t.co/mgRIph0zUD $1.06 BILLION paid to New England Journal of Medicine (NEJM) REVIEWERS! David-Dan Nguyen et al pub…
RT @jathorpmfm: https://t.co/mgRIph0zUD $1.06 BILLION paid to New England Journal of Medicine (NEJM) REVIEWERS! David-Dan Nguyen et al pub…
RT @jathorpmfm: https://t.co/mgRIph0zUD $1.06 BILLION paid to New England Journal of Medicine (NEJM) REVIEWERS! David-Dan Nguyen et al pub…
RT @jathorpmfm: https://t.co/mgRIph0zUD $1.06 BILLION paid to New England Journal of Medicine (NEJM) REVIEWERS! David-Dan Nguyen et al pub…
RT @jathorpmfm: https://t.co/mgRIph0zUD $1.06 BILLION paid to New England Journal of Medicine (NEJM) REVIEWERS! David-Dan Nguyen et al pub…
@grok @iconoclastia2 @leRaffl @stkirsch "The CDC and WHO confirm vaccines are safe" "Rely on peer-reviewed research for accurate information" Appeal to authority fallacy. https://t.co/VePPcfLeaX
Payments by Drug and Medical Device Manufacturers to US Peer Reviewers of Major Medical Journals - https://t.co/zOxf4uco98
RT @bigfatsurprise: Pharma companies paid over $1 Billion from 2020-2022 to pay scientists who review papers for US medical journals. How c…
RT @bigfatsurprise: Pharma companies paid over $1 Billion from 2020-2022 to pay scientists who review papers for US medical journals. How c…
Payments by Drug and Medical Device Manufacturers to US Peer Reviewers of Major Medical Journals | Medical Devices and Equipment | JAMA | JAMA Network https://t.co/jyN1lZQcFn
RT @WDINH2: Payments by Drug and Medical Device Manufacturers to US Peer Reviewers of Major Medical Journals | Medical Devices and Equipmen…
Payments by Drug and Medical Device Manufacturers to US Peer Reviewers of Major Medical Journals | Medical Devices and Equipment | JAMA | JAMA Network https://t.co/qWJVegcZ5C
@Zosogis @JoshWalkos Did you read the linked report @Zosogis? I didn't see any obvious flaws but let me know if you spot any. The limitations are all details and seem fair and straightforward. https://t.co/VKCbiOsF5J Summarised here: https://t.co/XO2U3N8T6x
RT @0waki: 論文査読者も製薬とか医療機器メーカーからけっこうな額を受け取ってるという話。まあ、そりゃそうだろう。 Payments by Drug and Medical Device Manufacturers to US Peer Reviewers of Ma…
RT @0waki: 論文査読者も製薬とか医療機器メーカーからけっこうな額を受け取ってるという話。まあ、そりゃそうだろう。 Payments by Drug and Medical Device Manufacturers to US Peer Reviewers of Ma…
RT @0waki: 論文査読者も製薬とか医療機器メーカーからけっこうな額を受け取ってるという話。まあ、そりゃそうだろう。 Payments by Drug and Medical Device Manufacturers to US Peer Reviewers of Ma…
RT @0waki: 論文査読者も製薬とか医療機器メーカーからけっこうな額を受け取ってるという話。まあ、そりゃそうだろう。 Payments by Drug and Medical Device Manufacturers to US Peer Reviewers of Ma…
RT @0waki: 論文査読者も製薬とか医療機器メーカーからけっこうな額を受け取ってるという話。まあ、そりゃそうだろう。 Payments by Drug and Medical Device Manufacturers to US Peer Reviewers of Ma…
RT @0waki: 論文査読者も製薬とか医療機器メーカーからけっこうな額を受け取ってるという話。まあ、そりゃそうだろう。 Payments by Drug and Medical Device Manufacturers to US Peer Reviewers of Ma…
RT @0waki: 論文査読者も製薬とか医療機器メーカーからけっこうな額を受け取ってるという話。まあ、そりゃそうだろう。 Payments by Drug and Medical Device Manufacturers to US Peer Reviewers of Ma…
RT @0waki: 論文査読者も製薬とか医療機器メーカーからけっこうな額を受け取ってるという話。まあ、そりゃそうだろう。 Payments by Drug and Medical Device Manufacturers to US Peer Reviewers of Ma…
RT @0waki: 論文査読者も製薬とか医療機器メーカーからけっこうな額を受け取ってるという話。まあ、そりゃそうだろう。 Payments by Drug and Medical Device Manufacturers to US Peer Reviewers of Ma…
RT @0waki: 論文査読者も製薬とか医療機器メーカーからけっこうな額を受け取ってるという話。まあ、そりゃそうだろう。 Payments by Drug and Medical Device Manufacturers to US Peer Reviewers of Ma…
RT @0waki: 論文査読者も製薬とか医療機器メーカーからけっこうな額を受け取ってるという話。まあ、そりゃそうだろう。 Payments by Drug and Medical Device Manufacturers to US Peer Reviewers of Ma…
RT @0waki: 論文査読者も製薬とか医療機器メーカーからけっこうな額を受け取ってるという話。まあ、そりゃそうだろう。 Payments by Drug and Medical Device Manufacturers to US Peer Reviewers of Ma…
RT @0waki: 論文査読者も製薬とか医療機器メーカーからけっこうな額を受け取ってるという話。まあ、そりゃそうだろう。 Payments by Drug and Medical Device Manufacturers to US Peer Reviewers of Ma…
RT @0waki: 論文査読者も製薬とか医療機器メーカーからけっこうな額を受け取ってるという話。まあ、そりゃそうだろう。 Payments by Drug and Medical Device Manufacturers to US Peer Reviewers of Ma…
RT @JAMA_current: This study characterizes payments by drug and medical device manufacturers to US peer reviewers of major medical journals…
Payments by Drug and Medical Device Manufacturers to US Peer Reviewers of Major Medical Journals https://t.co/K8ZkDNhiUQ https://t.co/KoEgvacQfu
RT @Sabisteb: @Michael__1967 @AnwaltUlbrich Payments by Drug and Medical Device Manufacturers to US Peer Reviewers of Major Medical Journal…
@Michael__1967 @FritziSoundso @AnwaltUlbrich Payments by Drug and Medical Device Manufacturers to US Peer Reviewers of Major Medical Journals | Medical Devices and Equipment | JAMA | JAMA Network https://t.co/rnUeuNAAd1
@Michael__1967 @AnwaltUlbrich Payments by Drug and Medical Device Manufacturers to US Peer Reviewers of Major Medical Journals | Medical Devices and Equipment | JAMA | JAMA Network https://t.co/rnUeuNAAd1
Payments by Drug and Medical Device Manufacturers to US Peer Reviewers of Major Medical Journals https://t.co/UgtwafCSE8
@travtravtrav @WallStreetApes @EndWokeness @JoeNBC forvthose interested, here is the full report https://t.co/xN13p6pumB
Pagamentos de fabricantes de medicamentos e dispositivos médicos à revisores das principais revistas médicas dos EUA. Payments by Drug and Medical Device Manufacturers to US Peer Reviewers of Major Medical Journals|Medical Devices & Equipment https://t.co/PR4se4oJ7C
Payments by Drug and Medical Device Manufacturers to US Peer Reviewers of Major Medical Journals David-Dan Nguyen, MDCM, MPH1,2; Anju Murayama3,4; Anna-Lisa Nguyen, JAMA. 2024;332(17):1480-1482. doi:10.1001/jama.2024.17681
This is why we need RFK Jr. Big Pharma is corrupt. Payments by Drug and Medical Device Manufacturers to US Peer Reviewers of Major Medical Journals | Medical Devices and Equipment | JAMA | JAMA Network https://t.co/tFYf1oGJ1m
RT @JAMA_current: This study characterizes payments by drug and medical device manufacturers to US peer reviewers of major medical journals…
RT @ChanceGardiner: Durante il COVlD, almeno il 54% dei revisori degli studi di riviste mediche e scientifiche, ha ricevuto denaro per alme…
RT @ChanceGardiner: Durante il COVlD, almeno il 54% dei revisori degli studi di riviste mediche e scientifiche, ha ricevuto denaro per alme…
RT @ChanceGardiner: Durante il COVlD, almeno il 54% dei revisori degli studi di riviste mediche e scientifiche, ha ricevuto denaro per alme…
RT @ChanceGardiner: Durante il COVlD, almeno il 54% dei revisori degli studi di riviste mediche e scientifiche, ha ricevuto denaro per alme…
RT @ChanceGardiner: Durante il COVlD, almeno il 54% dei revisori degli studi di riviste mediche e scientifiche, ha ricevuto denaro per alme…
RT @ChanceGardiner: Durante il COVlD, almeno il 54% dei revisori degli studi di riviste mediche e scientifiche, ha ricevuto denaro per alme…
RT @ChanceGardiner: Durante il COVlD, almeno il 54% dei revisori degli studi di riviste mediche e scientifiche, ha ricevuto denaro per alme…
Perhaps another reason we didnt get to hear the other side of scientific opinion during Covid "Payments by Drug and Medical Device Manufacturers to US Peer Reviewers of Major Medical Journals" https://t.co/pDU2EcCGuD
RT @ChanceGardiner: Durante il COVlD, almeno il 54% dei revisori degli studi di riviste mediche e scientifiche, ha ricevuto denaro per alme…
RT @ChanceGardiner: Durante il COVlD, almeno il 54% dei revisori degli studi di riviste mediche e scientifiche, ha ricevuto denaro per alme…
RT @ChanceGardiner: Durante il COVlD, almeno il 54% dei revisori degli studi di riviste mediche e scientifiche, ha ricevuto denaro per alme…
RT @0waki: 論文査読者も製薬とか医療機器メーカーからけっこうな額を受け取ってるという話。まあ、そりゃそうだろう。 Payments by Drug and Medical Device Manufacturers to US Peer Reviewers of Ma…
RT @ChanceGardiner: Durante il COVlD, almeno il 54% dei revisori degli studi di riviste mediche e scientifiche, ha ricevuto denaro per alme…
RT @ChanceGardiner: Durante il COVlD, almeno il 54% dei revisori degli studi di riviste mediche e scientifiche, ha ricevuto denaro per alme…
Over $1B in Payments by Drug and Medical Device Manufacturers to US Peer Reviewers of Major Medical Journals https://t.co/1SuDMXJVUI
RT @ChanceGardiner: Durante il COVlD, almeno il 54% dei revisori degli studi di riviste mediche e scientifiche, ha ricevuto denaro per alme…
RT @ChanceGardiner: Durante il COVlD, almeno il 54% dei revisori degli studi di riviste mediche e scientifiche, ha ricevuto denaro per alme…
RT @ChanceGardiner: Durante il COVlD, almeno il 54% dei revisori degli studi di riviste mediche e scientifiche, ha ricevuto denaro per alme…
RT @ChanceGardiner: Durante il COVlD, almeno il 54% dei revisori degli studi di riviste mediche e scientifiche, ha ricevuto denaro per alme…
RT @ChanceGardiner: Durante il COVlD, almeno il 54% dei revisori degli studi di riviste mediche e scientifiche, ha ricevuto denaro per alme…
RT @ChanceGardiner: Durante il COVlD, almeno il 54% dei revisori degli studi di riviste mediche e scientifiche, ha ricevuto denaro per alme…
RT @ChanceGardiner: Durante il COVlD, almeno il 54% dei revisori degli studi di riviste mediche e scientifiche, ha ricevuto denaro per alme…
RT @ChanceGardiner: Durante il COVlD, almeno il 54% dei revisori degli studi di riviste mediche e scientifiche, ha ricevuto denaro per alme…
RT @ChanceGardiner: Durante il COVlD, almeno il 54% dei revisori degli studi di riviste mediche e scientifiche, ha ricevuto denaro per alme…
RT @ChanceGardiner: Durante il COVlD, almeno il 54% dei revisori degli studi di riviste mediche e scientifiche, ha ricevuto denaro per alme…
RT @ChanceGardiner: Durante il COVlD, almeno il 54% dei revisori degli studi di riviste mediche e scientifiche, ha ricevuto denaro per alme…
RT @ChanceGardiner: Durante il COVlD, almeno il 54% dei revisori degli studi di riviste mediche e scientifiche, ha ricevuto denaro per alme…
RT @ChanceGardiner: Durante il COVlD, almeno il 54% dei revisori degli studi di riviste mediche e scientifiche, ha ricevuto denaro per alme…
RT @ChanceGardiner: Durante il COVlD, almeno il 54% dei revisori degli studi di riviste mediche e scientifiche, ha ricevuto denaro per alme…
RT @bigfatsurprise: Pharma companies paid over $1 Billion from 2020-2022 to pay scientists who review papers for US medical journals. How c…
RT @ChanceGardiner: Durante il COVlD, almeno il 54% dei revisori degli studi di riviste mediche e scientifiche, ha ricevuto denaro per alme…
RT @ChanceGardiner: Durante il COVlD, almeno il 54% dei revisori degli studi di riviste mediche e scientifiche, ha ricevuto denaro per alme…
RT @ChanceGardiner: Durante il COVlD, almeno il 54% dei revisori degli studi di riviste mediche e scientifiche, ha ricevuto denaro per alme…
RT @ChanceGardiner: Durante il COVlD, almeno il 54% dei revisori degli studi di riviste mediche e scientifiche, ha ricevuto denaro per alme…
RT @ChanceGardiner: Durante il COVlD, almeno il 54% dei revisori degli studi di riviste mediche e scientifiche, ha ricevuto denaro per alme…
Durante il COVlD, almeno il 54% dei revisori degli studi di riviste mediche e scientifiche, ha ricevuto denaro per almeno 1,06 miliardi di dollari dalle grandi aziende farmaceutiche, secondo quanto riportato da un nuovo studio su JAMA. 10.1001/jama.2024.17681 https://t.co/HrN79DYK7u
RT @0waki: 論文査読者も製薬とか医療機器メーカーからけっこうな額を受け取ってるという話。まあ、そりゃそうだろう。 Payments by Drug and Medical Device Manufacturers to US Peer Reviewers of Ma…
RT @0waki: 論文査読者も製薬とか医療機器メーカーからけっこうな額を受け取ってるという話。まあ、そりゃそうだろう。 Payments by Drug and Medical Device Manufacturers to US Peer Reviewers of Ma…
RT @0waki: 論文査読者も製薬とか医療機器メーカーからけっこうな額を受け取ってるという話。まあ、そりゃそうだろう。 Payments by Drug and Medical Device Manufacturers to US Peer Reviewers of Ma…
RT @0waki: 論文査読者も製薬とか医療機器メーカーからけっこうな額を受け取ってるという話。まあ、そりゃそうだろう。 Payments by Drug and Medical Device Manufacturers to US Peer Reviewers of Ma…
RT @JAMA_current: This study characterizes payments by drug and medical device manufacturers to US peer reviewers of major medical journals…
RT @0waki: 論文査読者も製薬とか医療機器メーカーからけっこうな額を受け取ってるという話。まあ、そりゃそうだろう。 Payments by Drug and Medical Device Manufacturers to US Peer Reviewers of Ma…
RT @0waki: 論文査読者も製薬とか医療機器メーカーからけっこうな額を受け取ってるという話。まあ、そりゃそうだろう。 Payments by Drug and Medical Device Manufacturers to US Peer Reviewers of Ma…
RT @0waki: 論文査読者も製薬とか医療機器メーカーからけっこうな額を受け取ってるという話。まあ、そりゃそうだろう。 Payments by Drug and Medical Device Manufacturers to US Peer Reviewers of Ma…
RT @0waki: 論文査読者も製薬とか医療機器メーカーからけっこうな額を受け取ってるという話。まあ、そりゃそうだろう。 Payments by Drug and Medical Device Manufacturers to US Peer Reviewers of Ma…
RT @0waki: 論文査読者も製薬とか医療機器メーカーからけっこうな額を受け取ってるという話。まあ、そりゃそうだろう。 Payments by Drug and Medical Device Manufacturers to US Peer Reviewers of Ma…
RT @0waki: 論文査読者も製薬とか医療機器メーカーからけっこうな額を受け取ってるという話。まあ、そりゃそうだろう。 Payments by Drug and Medical Device Manufacturers to US Peer Reviewers of Ma…
RT @0waki: 論文査読者も製薬とか医療機器メーカーからけっこうな額を受け取ってるという話。まあ、そりゃそうだろう。 Payments by Drug and Medical Device Manufacturers to US Peer Reviewers of Ma…
RT @0waki: 論文査読者も製薬とか医療機器メーカーからけっこうな額を受け取ってるという話。まあ、そりゃそうだろう。 Payments by Drug and Medical Device Manufacturers to US Peer Reviewers of Ma…
RT @0waki: 論文査読者も製薬とか医療機器メーカーからけっこうな額を受け取ってるという話。まあ、そりゃそうだろう。 Payments by Drug and Medical Device Manufacturers to US Peer Reviewers of Ma…
RT @JAMA_current: This study characterizes payments by drug and medical device manufacturers to US peer reviewers of major medical journals…
RT @0waki: 論文査読者も製薬とか医療機器メーカーからけっこうな額を受け取ってるという話。まあ、そりゃそうだろう。 Payments by Drug and Medical Device Manufacturers to US Peer Reviewers of Ma…
RT @0waki: 論文査読者も製薬とか医療機器メーカーからけっこうな額を受け取ってるという話。まあ、そりゃそうだろう。 Payments by Drug and Medical Device Manufacturers to US Peer Reviewers of Ma…
RT @JAMA_current: This study characterizes payments by drug and medical device manufacturers to US peer reviewers of major medical journals…
RT @0waki: 論文査読者も製薬とか医療機器メーカーからけっこうな額を受け取ってるという話。まあ、そりゃそうだろう。 Payments by Drug and Medical Device Manufacturers to US Peer Reviewers of Ma…
RT @0waki: 論文査読者も製薬とか医療機器メーカーからけっこうな額を受け取ってるという話。まあ、そりゃそうだろう。 Payments by Drug and Medical Device Manufacturers to US Peer Reviewers of Ma…
RT @0waki: 論文査読者も製薬とか医療機器メーカーからけっこうな額を受け取ってるという話。まあ、そりゃそうだろう。 Payments by Drug and Medical Device Manufacturers to US Peer Reviewers of Ma…
RT @0waki: 論文査読者も製薬とか医療機器メーカーからけっこうな額を受け取ってるという話。まあ、そりゃそうだろう。 Payments by Drug and Medical Device Manufacturers to US Peer Reviewers of Ma…
RT @0waki: 論文査読者も製薬とか医療機器メーカーからけっこうな額を受け取ってるという話。まあ、そりゃそうだろう。 Payments by Drug and Medical Device Manufacturers to US Peer Reviewers of Ma…
RT @0waki: 論文査読者も製薬とか医療機器メーカーからけっこうな額を受け取ってるという話。まあ、そりゃそうだろう。 Payments by Drug and Medical Device Manufacturers to US Peer Reviewers of Ma…
October 10, 2024 Payments by Drug and Medical Device Manufacturers to US Peer Reviewers of Major Medical Journals https://t.co/pdiejQWAxL
RT @JAMA_current: This study characterizes payments by drug and medical device manufacturers to US peer reviewers of major medical journals…
RT @JAMA_current: This study characterizes payments by drug and medical device manufacturers to US peer reviewers of major medical journals…
RT @0waki: 論文査読者も製薬とか医療機器メーカーからけっこうな額を受け取ってるという話。まあ、そりゃそうだろう。 Payments by Drug and Medical Device Manufacturers to US Peer Reviewers of Ma…
This study characterizes payments by drug and medical device manufacturers to US peer reviewers of major medical journals. https://t.co/uo74UIefhY https://t.co/JtPgo0fQgc
RT @0waki: 論文査読者も製薬とか医療機器メーカーからけっこうな額を受け取ってるという話。まあ、そりゃそうだろう。 Payments by Drug and Medical Device Manufacturers to US Peer Reviewers of Ma…
RT @0waki: 論文査読者も製薬とか医療機器メーカーからけっこうな額を受け取ってるという話。まあ、そりゃそうだろう。 Payments by Drug and Medical Device Manufacturers to US Peer Reviewers of Ma…
RT @0waki: 論文査読者も製薬とか医療機器メーカーからけっこうな額を受け取ってるという話。まあ、そりゃそうだろう。 Payments by Drug and Medical Device Manufacturers to US Peer Reviewers of Ma…
RT @0waki: 論文査読者も製薬とか医療機器メーカーからけっこうな額を受け取ってるという話。まあ、そりゃそうだろう。 Payments by Drug and Medical Device Manufacturers to US Peer Reviewers of Ma…
RT @0waki: 論文査読者も製薬とか医療機器メーカーからけっこうな額を受け取ってるという話。まあ、そりゃそうだろう。 Payments by Drug and Medical Device Manufacturers to US Peer Reviewers of Ma…
RT @0waki: 論文査読者も製薬とか医療機器メーカーからけっこうな額を受け取ってるという話。まあ、そりゃそうだろう。 Payments by Drug and Medical Device Manufacturers to US Peer Reviewers of Ma…
RT @0waki: 論文査読者も製薬とか医療機器メーカーからけっこうな額を受け取ってるという話。まあ、そりゃそうだろう。 Payments by Drug and Medical Device Manufacturers to US Peer Reviewers of Ma…
RT @0waki: 論文査読者も製薬とか医療機器メーカーからけっこうな額を受け取ってるという話。まあ、そりゃそうだろう。 Payments by Drug and Medical Device Manufacturers to US Peer Reviewers of Ma…
RT @0waki: 論文査読者も製薬とか医療機器メーカーからけっこうな額を受け取ってるという話。まあ、そりゃそうだろう。 Payments by Drug and Medical Device Manufacturers to US Peer Reviewers of Ma…
RT @0waki: 論文査読者も製薬とか医療機器メーカーからけっこうな額を受け取ってるという話。まあ、そりゃそうだろう。 Payments by Drug and Medical Device Manufacturers to US Peer Reviewers of Ma…
RT @0waki: 論文査読者も製薬とか医療機器メーカーからけっこうな額を受け取ってるという話。まあ、そりゃそうだろう。 Payments by Drug and Medical Device Manufacturers to US Peer Reviewers of Ma…
RT @0waki: 論文査読者も製薬とか医療機器メーカーからけっこうな額を受け取ってるという話。まあ、そりゃそうだろう。 Payments by Drug and Medical Device Manufacturers to US Peer Reviewers of Ma…
RT @0waki: 論文査読者も製薬とか医療機器メーカーからけっこうな額を受け取ってるという話。まあ、そりゃそうだろう。 Payments by Drug and Medical Device Manufacturers to US Peer Reviewers of Ma…
RT @0waki: 論文査読者も製薬とか医療機器メーカーからけっこうな額を受け取ってるという話。まあ、そりゃそうだろう。 Payments by Drug and Medical Device Manufacturers to US Peer Reviewers of Ma…
RT @0waki: 論文査読者も製薬とか医療機器メーカーからけっこうな額を受け取ってるという話。まあ、そりゃそうだろう。 Payments by Drug and Medical Device Manufacturers to US Peer Reviewers of Ma…
RT @0waki: 論文査読者も製薬とか医療機器メーカーからけっこうな額を受け取ってるという話。まあ、そりゃそうだろう。 Payments by Drug and Medical Device Manufacturers to US Peer Reviewers of Ma…
RT @0waki: 論文査読者も製薬とか医療機器メーカーからけっこうな額を受け取ってるという話。まあ、そりゃそうだろう。 Payments by Drug and Medical Device Manufacturers to US Peer Reviewers of Ma…
RT @0waki: 論文査読者も製薬とか医療機器メーカーからけっこうな額を受け取ってるという話。まあ、そりゃそうだろう。 Payments by Drug and Medical Device Manufacturers to US Peer Reviewers of Ma…
RT @0waki: 論文査読者も製薬とか医療機器メーカーからけっこうな額を受け取ってるという話。まあ、そりゃそうだろう。 Payments by Drug and Medical Device Manufacturers to US Peer Reviewers of Ma…
RT @0waki: 論文査読者も製薬とか医療機器メーカーからけっこうな額を受け取ってるという話。まあ、そりゃそうだろう。 Payments by Drug and Medical Device Manufacturers to US Peer Reviewers of Ma…
RT @0waki: 論文査読者も製薬とか医療機器メーカーからけっこうな額を受け取ってるという話。まあ、そりゃそうだろう。 Payments by Drug and Medical Device Manufacturers to US Peer Reviewers of Ma…
RT @0waki: 論文査読者も製薬とか医療機器メーカーからけっこうな額を受け取ってるという話。まあ、そりゃそうだろう。 Payments by Drug and Medical Device Manufacturers to US Peer Reviewers of Ma…
RT @0waki: 論文査読者も製薬とか医療機器メーカーからけっこうな額を受け取ってるという話。まあ、そりゃそうだろう。 Payments by Drug and Medical Device Manufacturers to US Peer Reviewers of Ma…
RT @0waki: 論文査読者も製薬とか医療機器メーカーからけっこうな額を受け取ってるという話。まあ、そりゃそうだろう。 Payments by Drug and Medical Device Manufacturers to US Peer Reviewers of Ma…
RT @0waki: 論文査読者も製薬とか医療機器メーカーからけっこうな額を受け取ってるという話。まあ、そりゃそうだろう。 Payments by Drug and Medical Device Manufacturers to US Peer Reviewers of Ma…
RT @0waki: 論文査読者も製薬とか医療機器メーカーからけっこうな額を受け取ってるという話。まあ、そりゃそうだろう。 Payments by Drug and Medical Device Manufacturers to US Peer Reviewers of Ma…
RT @0waki: 論文査読者も製薬とか医療機器メーカーからけっこうな額を受け取ってるという話。まあ、そりゃそうだろう。 Payments by Drug and Medical Device Manufacturers to US Peer Reviewers of Ma…
RT @0waki: 論文査読者も製薬とか医療機器メーカーからけっこうな額を受け取ってるという話。まあ、そりゃそうだろう。 Payments by Drug and Medical Device Manufacturers to US Peer Reviewers of Ma…
RT @0waki: 論文査読者も製薬とか医療機器メーカーからけっこうな額を受け取ってるという話。まあ、そりゃそうだろう。 Payments by Drug and Medical Device Manufacturers to US Peer Reviewers of Ma…
RT @0waki: 論文査読者も製薬とか医療機器メーカーからけっこうな額を受け取ってるという話。まあ、そりゃそうだろう。 Payments by Drug and Medical Device Manufacturers to US Peer Reviewers of Ma…
RT @0waki: 論文査読者も製薬とか医療機器メーカーからけっこうな額を受け取ってるという話。まあ、そりゃそうだろう。 Payments by Drug and Medical Device Manufacturers to US Peer Reviewers of Ma…
RT @0waki: 論文査読者も製薬とか医療機器メーカーからけっこうな額を受け取ってるという話。まあ、そりゃそうだろう。 Payments by Drug and Medical Device Manufacturers to US Peer Reviewers of Ma…
RT @0waki: 論文査読者も製薬とか医療機器メーカーからけっこうな額を受け取ってるという話。まあ、そりゃそうだろう。 Payments by Drug and Medical Device Manufacturers to US Peer Reviewers of Ma…
RT @bigfatsurprise: Pharma companies paid over $1 Billion from 2020-2022 to pay scientists who review papers for US medical journals. How c…
RT @bigfatsurprise: Pharma companies paid over $1 Billion from 2020-2022 to pay scientists who review papers for US medical journals. How c…
RT @bigfatsurprise: Pharma companies paid over $1 Billion from 2020-2022 to pay scientists who review papers for US medical journals. How c…
RT @bigfatsurprise: Pharma companies paid over $1 Billion from 2020-2022 to pay scientists who review papers for US medical journals. How c…
RT @bigfatsurprise: Pharma companies paid over $1 Billion from 2020-2022 to pay scientists who review papers for US medical journals. How c…
RT @bigfatsurprise: Pharma companies paid over $1 Billion from 2020-2022 to pay scientists who review papers for US medical journals. How c…
RT @bigfatsurprise: Pharma companies paid over $1 Billion from 2020-2022 to pay scientists who review papers for US medical journals. How c…
RT @bigfatsurprise: Pharma companies paid over $1 Billion from 2020-2022 to pay scientists who review papers for US medical journals. How c…
RT @bigfatsurprise: Pharma companies paid over $1 Billion from 2020-2022 to pay scientists who review papers for US medical journals. How c…
RT @bigfatsurprise: Pharma companies paid over $1 Billion from 2020-2022 to pay scientists who review papers for US medical journals. How c…
RT @bigfatsurprise: Pharma companies paid over $1 Billion from 2020-2022 to pay scientists who review papers for US medical journals. How c…
RT @bigfatsurprise: Pharma companies paid over $1 Billion from 2020-2022 to pay scientists who review papers for US medical journals. How c…
RT @bigfatsurprise: Pharma companies paid over $1 Billion from 2020-2022 to pay scientists who review papers for US medical journals. How c…
RT @bigfatsurprise: Pharma companies paid over $1 Billion from 2020-2022 to pay scientists who review papers for US medical journals. How c…
RT @bigfatsurprise: Pharma companies paid over $1 Billion from 2020-2022 to pay scientists who review papers for US medical journals. How c…
Payments by Drug and Medical Device Manufacturers to US Peer Reviewers of Major Medical Journals. David-Dan Nguyen et al. Research Letter published online JAMA October 10, 2024. doi:10.1001/jama.2024.17681
RT @bigfatsurprise: Pharma companies paid over $1 Billion from 2020-2022 to pay scientists who review papers for US medical journals. How c…
RT @bigfatsurprise: Pharma companies paid over $1 Billion from 2020-2022 to pay scientists who review papers for US medical journals. How c…
RT @bigfatsurprise: Pharma companies paid over $1 Billion from 2020-2022 to pay scientists who review papers for US medical journals. How c…
RT @bigfatsurprise: Pharma companies paid over $1 Billion from 2020-2022 to pay scientists who review papers for US medical journals. How c…
RT @bigfatsurprise: Pharma companies paid over $1 Billion from 2020-2022 to pay scientists who review papers for US medical journals. How c…
RT @bigfatsurprise: Pharma companies paid over $1 Billion from 2020-2022 to pay scientists who review papers for US medical journals. How c…
RT @bigfatsurprise: Pharma companies paid over $1 Billion from 2020-2022 to pay scientists who review papers for US medical journals. How c…
RT @bigfatsurprise: Pharma companies paid over $1 Billion from 2020-2022 to pay scientists who review papers for US medical journals. How c…
RT @bigfatsurprise: Pharma companies paid over $1 Billion from 2020-2022 to pay scientists who review papers for US medical journals. How c…
RT @bigfatsurprise: Pharma companies paid over $1 Billion from 2020-2022 to pay scientists who review papers for US medical journals. How c…
RT @bigfatsurprise: Pharma companies paid over $1 Billion from 2020-2022 to pay scientists who review papers for US medical journals. How c…
RT @bigfatsurprise: Pharma companies paid over $1 Billion from 2020-2022 to pay scientists who review papers for US medical journals. How c…
RT @bigfatsurprise: Pharma companies paid over $1 Billion from 2020-2022 to pay scientists who review papers for US medical journals. How c…
RT @bigfatsurprise: Pharma companies paid over $1 Billion from 2020-2022 to pay scientists who review papers for US medical journals. How c…
RT @bigfatsurprise: Pharma companies paid over $1 Billion from 2020-2022 to pay scientists who review papers for US medical journals. How c…
RT @bigfatsurprise: Pharma companies paid over $1 Billion from 2020-2022 to pay scientists who review papers for US medical journals. How c…
RT @bigfatsurprise: Pharma companies paid over $1 Billion from 2020-2022 to pay scientists who review papers for US medical journals. How c…
RT @bigfatsurprise: Pharma companies paid over $1 Billion from 2020-2022 to pay scientists who review papers for US medical journals. How c…
RT @bigfatsurprise: Pharma companies paid over $1 Billion from 2020-2022 to pay scientists who review papers for US medical journals. How c…
RT @bigfatsurprise: Pharma companies paid over $1 Billion from 2020-2022 to pay scientists who review papers for US medical journals. How c…
RT @bigfatsurprise: Pharma companies paid over $1 Billion from 2020-2022 to pay scientists who review papers for US medical journals. How c…
RT @bigfatsurprise: Pharma companies paid over $1 Billion from 2020-2022 to pay scientists who review papers for US medical journals. How c…
RT @bigfatsurprise: Pharma companies paid over $1 Billion from 2020-2022 to pay scientists who review papers for US medical journals. How c…
RT @bigfatsurprise: Pharma companies paid over $1 Billion from 2020-2022 to pay scientists who review papers for US medical journals. How c…
RT @bigfatsurprise: Pharma companies paid over $1 Billion from 2020-2022 to pay scientists who review papers for US medical journals. How c…
RT @bigfatsurprise: Pharma companies paid over $1 Billion from 2020-2022 to pay scientists who review papers for US medical journals. How c…
RT @bigfatsurprise: Pharma companies paid over $1 Billion from 2020-2022 to pay scientists who review papers for US medical journals. How c…
RT @bigfatsurprise: Pharma companies paid over $1 Billion from 2020-2022 to pay scientists who review papers for US medical journals. How c…
RT @bigfatsurprise: Pharma companies paid over $1 Billion from 2020-2022 to pay scientists who review papers for US medical journals. How c…
RT @bigfatsurprise: Pharma companies paid over $1 Billion from 2020-2022 to pay scientists who review papers for US medical journals. How c…
RT @bigfatsurprise: Pharma companies paid over $1 Billion from 2020-2022 to pay scientists who review papers for US medical journals. How c…
RT @bigfatsurprise: Pharma companies paid over $1 Billion from 2020-2022 to pay scientists who review papers for US medical journals. How c…
RT @bigfatsurprise: Pharma companies paid over $1 Billion from 2020-2022 to pay scientists who review papers for US medical journals. How c…
RT @bigfatsurprise: Pharma companies paid over $1 Billion from 2020-2022 to pay scientists who review papers for US medical journals. How c…
RT @bigfatsurprise: Pharma companies paid over $1 Billion from 2020-2022 to pay scientists who review papers for US medical journals. How c…
RT @bigfatsurprise: Pharma companies paid over $1 Billion from 2020-2022 to pay scientists who review papers for US medical journals. How c…
RT @bigfatsurprise: Pharma companies paid over $1 Billion from 2020-2022 to pay scientists who review papers for US medical journals. How c…
RT @bigfatsurprise: Pharma companies paid over $1 Billion from 2020-2022 to pay scientists who review papers for US medical journals. How c…
RT @bigfatsurprise: Pharma companies paid over $1 Billion from 2020-2022 to pay scientists who review papers for US medical journals. How c…
RT @bigfatsurprise: Pharma companies paid over $1 Billion from 2020-2022 to pay scientists who review papers for US medical journals. How c…
RT @bigfatsurprise: Pharma companies paid over $1 Billion from 2020-2022 to pay scientists who review papers for US medical journals. How c…